Exogenus Therapeutics

Portugal
Cantanhede, Coimbra, Portugal, 3060-197

Company profile

Exogenus Therapeutics company profile

Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions. Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product, Exo-Wound, for the treatment of chronic wounds. The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.

Business identity

Contact email
[email protected]
Phone number
+351 231 419 040
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-06-02

Headquarters

Postal code
3060-197
Country code
PT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Private Equity
Funding rounds
4
Total equity funding
$870,487
Last funding
Private Equity / 2024-04-24
Last equity funding
Private Equity
Investors
6
Lead investors
3
Founders
3
Articles
2

Founders and investors

Founders

Joana Simões CorreiaLuisa MarquesRicardo Neves

Lead investors

3xP GlobalCaixa CapitalEISMEA

Investors

3xP GlobalBlue Bio ValueCaixa CapitalEISMEAmaze impact